Dr. Andrew J. Huang
Claim this profileAspirus Regional Cancer Center
Expert in Skin Cancer
Expert in Lung Cancer
66 reported clinical trials
138 drugs studied
About Andrew J. Huang
Education:
- Obtained a Medical degree (MD) from the University of Wisconsin School of Medicine and Public Health in 2015.
- Completed Residency in Radiation Oncology at the University of Wisconsin Hospital and Clinics in 2020.
- Finished a Fellowship in Stereotactic Body Radiotherapy (SBRT) and Stereotactic Radiosurgery (SRS) in 2021 at the same institution.
Experience:
- Currently practices as a Radiation Oncologist at Aspirus Regional Cancer Center.
Area of expertise
1Skin Cancer
Global LeaderStage IV
Stage II
Stage III
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Andrew J. Huang is currently running
Chemotherapy + Immunotherapy
for Esophageal and Gastric Cancer
This phase III trial compares the effect of modified fluorouracil, leucovorin calcium, oxaliplatin, and irinotecan (mFOLFIRINOX) to modified fluorouracil, leucovorin calcium, and oxaliplatin (mFOLFOX) for the treatment of advanced, unresectable, or metastatic HER2 negative esophageal, gastroesophageal junction, and gastric adenocarcinoma. The usual approach for patients is treatment with FOLFOX chemotherapy. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Fluorouracil stops cells from making DNA and it may kill tumor cells. Leucovorin is used with fluorouracil to enhance the effects of the drug. Oxaliplatin works by killing, stopping, or slowing the growth of tumor cells. Some patients also receive an immunotherapy drug, nivolumab, in addition to FOLFOX chemotherapy. Immunotherapy may induce changes in body's immune system and may interfere with the ability of tumor cells to grow and spread. Irinotecan blocks certain enzymes needed for cell division and DNA repair, and it may kill tumor cells. Adding irinotecan to the FOLFOX regimen could shrink the cancer and extend the life of patients with advanced gastroesophageal cancers.
Recruiting2 awards Phase 32 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
More about Andrew J. Huang
Clinical Trial Related2 years of experience running clinical trials · Led 66 trials as a Principal Investigator · 51 Active Clinical TrialsTreatments Andrew J. Huang has experience with
- Pembrolizumab
- Radiation Therapy
- Fluorouracil
- Cisplatin
- Atezolizumab
- Nivolumab
Breakdown of trials Andrew J. Huang has run
Skin Cancer
Lung Cancer
Breast Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrew J. Huang specialize in?
Andrew J. Huang focuses on Skin Cancer and Lung Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are Stage II.
Is Andrew J. Huang currently recruiting for clinical trials?
Yes, Andrew J. Huang is currently recruiting for 49 clinical trials in Wausau Wisconsin. If you're interested in participating, you should apply.
Are there any treatments that Andrew J. Huang has studied deeply?
Yes, Andrew J. Huang has studied treatments such as Pembrolizumab, Radiation Therapy, Fluorouracil.
What is the best way to schedule an appointment with Andrew J. Huang?
Apply for one of the trials that Andrew J. Huang is conducting.
What is the office address of Andrew J. Huang?
The office of Andrew J. Huang is located at: Aspirus Regional Cancer Center, Wausau, Wisconsin 54401 United States. This is the address for their practice at the Aspirus Regional Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.